Drug Type Monoclonal antibody |
Synonyms GNK 301, GNK301 |
Target |
Mechanism env inhibitors(Recombinant envelope protein inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis 1 | Preclinical | CH | 30 Jan 2022 | |
Amyotrophic Lateral Sclerosis | Preclinical | US | 05 Oct 2018 |